Clinical Trials Logo

Major Depression clinical trials

View clinical trials related to Major Depression.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05964192 Recruiting - Major Depression Clinical Trials

Added Value of a Neuroendocrine Test Battery in the Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment

Endo-rTMS
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The primary objective of the study is to determine the predictive value of the neuroendocrine tests TRH-∆∆TSH (thyreoliberin - thyreostimulin) and DST (dexamethasone suppression test) in the subsequent response to rTMS-TBS (repetitive transcranial magnetic stimulation-theta burst stimulation) treatment, defined as at least a 50% decrease in depression score after 20 sessions of rTMS-TBS.

NCT ID: NCT05964023 Recruiting - Major Depression Clinical Trials

pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDD

Start date: August 20, 2023
Phase: N/A
Study type: Interventional

The investigators aim to investigate whether the intervention effect of pBFS-guided rTMS therapy targeting DLPFC is superior to the intervention effect of the traditional "5 cm-rule" guided rTMS therapy in patients with depressive disorders.

NCT ID: NCT05669703 Recruiting - Bipolar Disorder Clinical Trials

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

Start date: November 3, 2023
Phase:
Study type: Observational

Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse substances. In this natural history study, researchers would like to learn more about the connection between exercise and mental health in people with and without mood disorders. Objective: To better understand relationships among physical activity, sleep, and mental health. Eligibility: People aged 12 to 60 years with a history of a mood disorder. Healthy spouses and relatives with no mood disorders are also needed. Design: Participants will be in the study up to 2 years. For up to 20 days in a row, at 4 times during the study, participants will: Complete an electronic diary on their smartphone. Participants will answer questions about their mood, health, sleep, and daily activities. Wear an activity monitor, like a wristwatch, that records how much they move. Wear a light sensor, as a necklace, to record the amount of light in their environment. Some participants will do additional tests. Twice during the study, for 3 days in a row, they will: Wear monitors to record their temperature, heart rate, and sleep. Provide saliva samples. Complete cognitive tasks on their smartphone. Participants will visit the NIH clinic 2 times. They will have a physical exam, with blood and urine tests. They will wear a heart monitor. They will ride a stationary bike for 30 minutes. They may have an imaging scan. Some participants will stay overnight. They will go to sleep wearing a cap to measure their brain activity.

NCT ID: NCT05608135 Recruiting - Major Depression Clinical Trials

AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder

Start date: December 1, 2022
Phase:
Study type: Observational

At present, diagnosis and recognition of depression and bipolar disorder are mainly based on subjective evidence such as clinical interview and scale evaluation. The corresponding diagnosis basis has some shortcomings, such as poor diagnostic reliability and failure in early identification of bipolar disorder. Therefore, it is of great significance to explore objective diagnostic indicators to remedy the deficiencies. Therefore,the investigators collect psychological and physiological information data of patients with bipolar disorder and depression.Then the investigators aim to construct and verify the multidimensional emotion recognition model to analyze the personality characteristics, negative emotions and cognitive reactions of different individuals, and form a systematic accurate recognition and evaluation tool.

NCT ID: NCT05575960 Recruiting - Major Depression Clinical Trials

Interpersonal Psychotherapy for Adolescents and Young Adults

Start date: October 3, 2022
Phase: N/A
Study type: Interventional

The purpose of the project is to study the effectiveness of Interpersonal Psychotherapy (IPT) for adolescents and young adults when applied to depression and eating disorders. Specific aims are to analyze the effects, change mechanisms, predictors, and implementation of IPT for youth. In this four-year project we will include 120 patients with depression and 60 adolescents and young adults with eating disorders. Outcome will be studied using a quasi-experimental multiple-baseline design. Change mechanisms will be studied in the form of mentalizing, emotion regulation, social support, and working alliance session-by-session, and with post-treatment qualitative interviews about the participants' experiences of change. Predictors of effectiveness of IPT for adolescents and young adults will be explored by measuring severity of symptoms, anxiety symptoms, presence and severity of parent-child conflicts, quality of interpersonal relationships, experiences of bullying, and school functioning. The implementation process of IPT for youth will be studied through interviews with adolescents, parents, therapists, co-workers, and local managers. The study is a multi-center study within child and adolescent psychiatric services in Gothenburg and Norrköping using a practice-oriented research strategy which emphasizes close collaboration with clinicians. The project is a collaboration between researchers at Linnaeus University, Linköping University, and University of Gothenburg, and clinicians at the BUP Norrköping and Ätstörningscentrum Barn och Unga Vuxna, Sahlgrenska University Hospital.

NCT ID: NCT05551585 Recruiting - Major Depression Clinical Trials

Transcranial Pulse Stimulation for Depression

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Transcranial pulse stimulation (TPS) is a newly developed brain stimulation therapy from Austria & Germany with highly promising applicability in neuropsychiatric disorders. Major depressive disorder (MDD) is the world's leading cause of disability. Novel treatment approaches are urgently needed given that a significant fraction of patients does not sufficiently respond to standard antidepressant treatments. Our open-label pilot study using TPS in MDD indicates preliminary efficacy. However, experimental control is necessary to infer reliable scientific evidence for the efficacy of TPS. Here, we propose a randomized, double-blind, sham-controlled clinical trial to probe the utility of TPS as a modern antidepressant treatment.

NCT ID: NCT05497414 Recruiting - Major Depression Clinical Trials

Neuroimaging Sleep and Mood in Depression

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

This study will investigate how sleep and mood are related in patients with depression and in healthy controls. It will use MRI-based measures of brain function to determine how neural systems are modulated by sleep and sleep deprivation, and its links to mood in depression.

NCT ID: NCT05097586 Recruiting - Pregnancy Clinical Trials

RCT of At-Home tDCS for Depression in Pregnancy

Start date: November 8, 2021
Phase: N/A
Study type: Interventional

This is a randomized, sham-controlled trial to determine whether treatment with transcranial direct current stimulation (tDCS) is superior to a sham condition at reducing the symptoms of depression in pregnant people with moderate to severe depression. The study aims to enrol 156 participants across all sites. Data collection occurs at baseline, immediately after treatment, every 4 weeks during pregnancy and 4-, 12-, 26- and 52-weeks postpartum

NCT ID: NCT04898725 Recruiting - Clinical trials for Vitamin D Deficiency

Effects of Vitamin D Supplementation on Depression and Inflammatory Markers

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

The current study is designed as a prospective partially randomized patient preference (PRPP) trial and recruit psychiatric outpatients or inpatients. Participants who agree to receive randomization will be randomly assigned into a supplementation or placebo group, after stratification for pre-intervention vitamin D status (12-20 ng/mL or <12 ng/mL) and depression status (HDRS-17 ≥ 17 or < 17). Participants who decline randomization but agree to receive follow-up in the observational cohort choose their preferred method (either 4800 IU vitamin D3 per day, or usual care without supplementation). Severity of depression, any change of medication, and side effect will be assessed at baseline and at 2-week intervals for 8 weeks. Serum levels of 25(OH)D, C-Reactive protein (CRP) and 12 cytokines, anthropometrical measurements, dietary intake, physical activity and sun exposure will be assessed at baseline and post-intervention. Additionally, serum levels of 25(OH)D will be assessed at 4 weeks to ensure its safety level.

NCT ID: NCT04872465 Recruiting - Major Depression Clinical Trials

TBS Over DLPFC in Elderly Refractory Depression

Start date: July 6, 2022
Phase: N/A
Study type: Interventional

The study aim to examine the effect of Thea-burst stimulation over bilateral dorsolateral prefrontal cortex (DLPFC) among patients with LLD on mood condition and relevant biomarkers.